Home・Akcijų sąrašas・Vericel Corp

Vericel Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

46.28 1.25

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

45.71

Max

47.15

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-30M -6.3M
Pardavimai	-24M 68M
P/E Sektoriaus vid.	105.395 64.641
Pelnas, tenkantis vienai akcijai	-0.12
Pelno marža	-9.21
Darbuotojai	398
EBITDA	-30M -2.9M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+33.81% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	456M 2.3B
Ankstesnė atidarymo kaina	45.03
Ankstesnė uždarymo kaina	46.28

Naujienos nuotaikos

By Acuity

100%

320 / 340 reitingas Healthcare

Vericel Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 20:03; UTC

Correlated Moves

Vericel Corp shares are advancing, supported by significant gains in the broader market and major tech stocks, contributing to positive investor sentiment.

2026-07-31 20:02; UTC

Correlated Moves

Vericel Corp's price is lower today, influenced by declines in the Biotechnology sub-sector and a falling Russell 2000 Index.

2026-07-30 20:36; UTC

Correlated Moves

Vericel Corp shares gained in after-market trading, aligning with a rising Russell 2000 Index. The stock remains above its 20-day moving average.

2026-07-29 19:27; UTC

Correlated Moves

Vericel Corp shares declined during Wednesday's session, continuing a downward trend since Tuesday's close, amid broader market weakness reflected in the Russell 2000 Index.

2026-07-28 21:02; UTC

Vericel Corp shares are lower in after-market trading, reflecting broader market caution amid declines in the Nikkei 225 Index and technology sector concerns.

2026-07-27 20:31; UTC

Vericel Corp shares declined during after-market hours amid unusual selling pressure. The stock remains below its 20-day moving average with no specific news identified.

2026-07-24 19:46; UTC

Correlated Moves

Vericel Corp reported first-quarter revenue of $39.2 million, missing estimates. Shares are lower amid broader market declines affecting small-cap biotechnology stocks.

2026-07-22 20:13; UTC

Vericel Corp shares are trading higher in after-market hours, influenced by broader market volatility amid rising crude oil prices and geopolitical tensions.

2026-07-21 14:31; UTC

Vericel Corp shares are higher, supported by overall market momentum and a recovery in Asian markets, particularly the Nikkei 225 Index.

2026-07-20 17:46; UTC

Correlated Moves

Vericel Corp shares are lower today, aligning with a decline in the ARK Genomic Revolution ETF and the Russell 2000 Index.

Akcijų palyginimas

Kainos pokytis

Vericel Corp Prognozė

Kainos tikslas

By TipRanks

33.81% į viršų

12 mėnesių prognozė

Vidutinis 61.5 USD 33.81%

Aukščiausias 72 USD

Žemiausias 58 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vericel Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių Vericel Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.